共 50 条
- [31] A safety and feasibility trial of 131I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group studyPEDIATRIC BLOOD & CANCER, 2021, 68 (10)Weiss, Brian D.Yanik, GregoryNaranjo, ArleneZhang, Fan F.Fitzgerald, WendyShulkin, Barry L.Parisi, Marguerite T.Russell, HeidiGrupp, StephanPater, LukeMattei, PeterMosse, YaelLai, Hollie A.Jarzembowski, Jason A.Shimada, HiroyukiVillablanca, Judith G.Giller, RogerBagatell, RochellePark, Julie R.Matthay, Katherine K.
- [32] Tandem High-Dose 131I-MIBG Therapy For Paediatric Patients With Relapsed-Refractory High Risk Neuroblastoma: A Dosimetry Based TreatmentEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S689 - S689Altini, C.Villani, M.Cassano, B.Pizzoferro, M.Serra, A.Castellano, A.Cannata, V.Garganese, M.
- [33] 177Lu-DOTATATE radionuclide therapy for pediatric patients with relapsed high-risk neuroblastoma negative on 131I-MIBG imaging - a pilot studyJOURNAL OF NUCLEAR MEDICINE, 2018, 59Chen, SirongCheung, WilliamLeung, Yim LungCheng, KamWong, Ka NinWong, Yuet HungHo, Chi-Lai
- [34] Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation with TTC/MEC REGIMENS ± 131I-MIBG for High-Risk NeuroblastomaPEDIATRIC BLOOD & CANCER, 2019, 66 : S338 - S338Park, H. J.Choi, J. Y.Kang, H. J.Kim, B. K.Hong, K. T.Kim, H. Y.Kim, I. H.Cheon, G. J.Cheon, J. E.Park, S. H.Shin, H. Y.
- [35] Feasibility of Administering High-Dose 131I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined RoomsPEDIATRIC BLOOD & CANCER, 2016, 63 (05) : 801 - 807Chu, Bae P.Horan, ChristopherBasu, EllenDauer, LawrenceWilliamson, MatthewCarrasquillo, Jorge A.Pandit-Taskar, NeetaModak, Shakeel
- [36] A correlation study between clinical outcome and absorbed dose to organs at risk and lesions for patients with High-Risk Neuroblastoma administered with high-activity therapy of 131I-mIBGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S315 - S316Cassano, B.Pizzoferro, M.Valeri, S.Donatiello, S.Polito, C.Ciucci, D.Martire, F.Castellano, A.Altini, C.Garganese, M. C.Cannata, V.
- [37] Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with 131I-MIBG therapy for high-risk neuroblastomaPEDIATRIC TRANSPLANTATION, 2020, 24 (02)Suh, Jin KyungKoh, Kyung-NamMin, So YoonKim, Young SunKim, HyeryIm, Ho JoonNamgoong, Jung-ManKim, Dae YeonAhn, Seung DoLee, Jong JinSeo, Jong Jin
- [38] Assessment of the dicentric chromosome assay as a biodosimetry tool for more personalized medicine in a case of a high risk neuroblastoma 131I-mIBG treatmentINTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2018, 95 (03) : 314 - 320Maria Chimeno, JoseSebastia, NatividadTorres-Espallardo, IreneBalaguer, JuliaCandela-Juan, CristianLuis Loaiza, JoseAdria, MarIbanez-Rosello, BlancaCanete, AdelaMarti-Bonmati, LuisMontoro, Alegria
- [39] Effect of Using Tungsten Apron for Occupational Radiation Exposure in Nurses during Care of 131I-mIBG Therapy for Children with High-risk NeuroblastomaJOURNAL OF NUCLEAR MEDICINE, 2021, 62Wakabayashi, HiroshiTaniguchi, YukaYamada, MasakoMorino, KeiOtosaki, AkikoInaki, AnriKayano, DaikiWatanabe, SatoruHiromasa, TomoMori, HiroshiYamase, TakafumiKunita, YujiSaito, ShintaroKinuya, Seigo
- [40] Response Assessment of 131I-mIBG-therapy in high-risk neuroblastoma patients: SIOPEN or Curie scoreEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S590 - S590Schmidt, M. C.Plum, G.Gecht, J.Berthold, F.Hero, B.Drzezga, A.Simon, T.Decarolis, B.